Eiger BioPharmaceuticals, Inc. financial data

Location
Palo Alto, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2023 - 08 Apr 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,480,797 shares -97%